Daniel J. Hasler
Vice President, Global Brands
Eli Lilly and Company
Office Address Home Address
Eli Lilly and Company 7251 North Pennsylvania
Faris I Campus Indianapolis, Indiana 46240
Indianapolis, Indiana 46285 Tel: 317-257-7251
Tel: 317-276-0414 Email:
Mobil: 317-457-1022
Email:
2001 - Present Vice President, Global Brands, Eli Lilly.
Responsible for global pre and post launch commercial strategy for all Lilly pharmaceutical brands from Phase I development to patent expiry.
Selected by the Chairman of the Board to receive the Chairman’s Ovation Award, based on strong leadership and entrepreneurial behavior.
1998 – 2001 Vice President, Marketing and Strategy, Eli Lilly USA.
Responsible for business and brand strategy development and implementation for all Lilly products marketed in the U.S. market. Profit and loss responsibility for over $6 billion in sales and related profitability targets.
1995 – 1998 President and General Manager, Eli Lilly, (Benelux, Nordic, Portugal).
Brussels, Belgium.
Responsible for coordination, management and profitability of the 9 countries comprising the BNP Region. Twelve direct reports, including 9 country based Managing Directors, 700 employees, $320 MM Annual sales Volume. Portfolio of Products included Central Nervous System, Infectious Disease, Cardiovascular, Oncology and Endocrine.
1993 – 1995 President and General Manager, Eli Lilly Brazil LTD. Sao Paulo, Brazil
Responsible for the earnings growth of a fully integrated Sales/Manufacturing operation including Marketing, Medical, Regulatory, Administration and Bulk Manufacturing. Nine direct reports, 1000 employees, and $260 MM in Annual Sales Volume. Responsible for managing this operation through the transition from hyperinflation to the current relative economic stability of the Real Plan. Annual Business Unit Contribution increased during this period 80%.
1992 – 1993 Director, Global Market Research and New Product Planning, Lilly
Corporate Headquarters, Indianapolis, Indiana
Responsible for forecasting, positioning and prioritization of research pipeline products both internally innovated and licensed. Created in conjunction with Lilly Research Labs, the first decision sciences based prioritization of Lilly’s research portfolio, resulting in a dramatic streamlining of research projects from 72 to 30. This process continues on today.
1990 – 1992 Director, Prozac Market Planning, U.S. Affiliate, Eli Lilly, Indianapolis,
Indiana
1988 – 1990 Director of Human Resources, Eli Lilly, Indianapolis, Indiana
1987 – 1988 Director of New Product Planning and Strategic Planning, IVAC Medical
Devices Corporation, San Diego, California.
1985 – 1987 Manager, Marketing and Sales, IVAC Corporation, San Diego, California
(At this time a wholly owned subsidiary of Eli Lilly and Company.)
EDUCATION
1982 Fuqua School of Business, Duke University, Durham, North Carolina
Fuqua Scholar, Full Academic Scholarship, Class President
1980 DePauw University, Greencastle, Indiana
Bachelors of Arts, Economics, and Physics.
Cum Laude, Senior Class President.
Elected by peers as outstanding graduate of 1980.
Community
Board of Visitors, DePauw University
Board of Directors, American Chamber of Commerce, San Paulo, Brazil
Board of Directors, American School in Sao Paulo, Brazil
Board of Directors, Junior Achievement
United Way Committee, Chairperson
Board of Directors, Indiana Center for Technologies
Board of Directors, Indiana Society for the Arts
Personal
Wife, Kathy; children, Daniel 14, Brooke 13
Hobbies: private pilot, scuba diving, outdoor sports, and jazz trombone
Language Skills: English, conversational Portuguese